That makes our mission very personal. After all, everyone we’re trying to reach is somebody’s friend, neighbor or family member, including our own. In fact, our quality products probably are in your medicine cabinet now.
in savings from generics in 2017
in savings from Mylan generics in 2017
In 2017, generics filled 90% of all prescriptions dispensed in the U.S., saving our healthcare system billions of dollars. Mylan knows people are concerned about the price of prescription drugs.
That’s why we continue to leverage our heritage as a generic drug manufacturer.
Mylan offers medicines that address a range of health concerns around the U.S. from the common cold to serious diseases like cancer, autoimmune disorders, diabetes, respiratory conditions and Alzheimer’s.
Not only is Mylan a leader in the fight against many of our nation’s most prevalent diseases, we filled more prescriptions in 2016 than AstraZeneca, GSK, Johnson & Johnson, Lilly, Merck, Pfizer and Sanofi COMBINED
in the U.S. will fight cancer in their lifetime.1
in the U.S. are living with COPD3
people receive ARV treatments in developing countries.
people are managing their diabetes in the U.S.4
The majority of Mylan’s doses sold in America are manufactured in America.*
*Manufactured from domestic and imported components
Mylan has one of the industry’s broadest pipelines with >200 applications pending approval at FDA
In the last five years,
Mylan launched more generics than any other company.